<?xml version="1.0" encoding="UTF-8"?>
<p id="p0125">Moreover, the viral spike protein is able to induce a TNF-α-converting enzyme (TACE)-dependent shedding of the ACE2 ectodomain, crucial for the penetration of the virus into the cell [
 <xref rid="bb0495" ref-type="bibr">99</xref>]. Since this process seems to be strictly coupled to TNFα production, it has been postulated that the use of TNF inhibitors may be effective in reducing both SARS-CoV2 infection and the consequent organ damage [
 <xref rid="bb0500" ref-type="bibr">100</xref>]. As a result, a study evaluating adalimumab in COVID-19 infection has recently been registered in the Chinese Clinical Trial Registry (ChiCTR2000030089).
</p>
